Cam Gallagher is Immusoft’s Chief Business Officer, joining the company in April of 2018. He has served in various senior management leadership and director roles with several biotech companies from formation through financing and successful acquisitions.
His previous and current roles include Retrosense Therapeutics (acquired by Allergan), Zavante Therapeutics, Oncternal Therapeutics, Velos BioPharma and Kalyra Pharmaceuticals. He was previously Managing Director of Nerveda, LLC, a life science seed fund he co-founded in June 2007.
Cam also served in various senior marketing positions of increasing responsibility at Verus Pharmaceuticals, a privately held specialty pharmaceutical company in San Diego, Calif. Prior to his role at Verus Pharmaceuticals he held positions of increasing management responsibilities at CV Therapeutics and Dura Pharmaceuticals (acquired by Elan).
He holds an M.B.A. from the University of San Diego and a B.S. in Business Administration from the Ohio University.